Literature DB >> 666468

Streptococcus bovis bacteremia and underlying gastrointestinal disease.

H W Murray, R B Roberts.   

Abstract

Twenty-six adults with Streptococcus bovis endocarditis and ten with bacteremia alone were studied to determine possible portals of entry. Of 36 patients (17 with endocarditis, eight with bacteremia alone), 25 had gastrointestinal lesions or manipulation. In 22, the gastrointestinal tract appeared to be the source of S bovis bacteremia. Four patients had either carcinoma of the colon (two) or potentially malignant villous adenomas (two) when first seen because of S bovis bacteremia. None of these, nor two other patients with benign colonic polyps, had bowel-related symptoms or signs prior to admission. Since S bovis is a normal intestinal tract inhabitant, bacteremia may frequently be associated with bowel lesions. Streptococcus bovis bacteremia may provide an early clue to the presence of serious and clinically unexpected gastrointestinal disease. Gastrointestinal tract evaluation should be part of S bovis bacteremia patient management, with or without endocarditis.

Entities:  

Mesh:

Year:  1978        PMID: 666468

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  36 in total

1.  Helicobacter pylori infection and colorectal carcinoma: is there a causal association?

Authors:  Sergei F Tatishchev; Christine Vanbeek; Hanlin L Wang
Journal:  J Gastrointest Oncol       Date:  2012-12

2.  Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates.

Authors:  K L Ruoff; S I Miller; C V Garner; M J Ferraro; S B Calderwood
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

3.  Rapid identification of Streptococcus bovis by using combination constitutive enzyme substrate hydrolyses.

Authors:  K J Panosian; S C Edberg
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

4.  The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease.

Authors:  B A Zarkin; K D Lillemoe; J L Cameron; P N Effron; T H Magnuson; H A Pitt
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

Review 5.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

Review 6.  Neonatal sepsis caused by Streptococcus bovis variant (biotype II/2): report of a case and review.

Authors:  Patrick J Gavin; Richard B Thomson; Show-Jen Horng; Ram Yogev
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Prevalence of the erm(T) gene in clinical isolates of erythromycin-resistant group D Streptococcus and Enterococcus.

Authors:  Linda P DiPersio; Joseph R DiPersio; Kevin C Frey; Jacqueline A Beach
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

8.  Identification of Streptococcus bovis biotype I strains among S. bovis clinical isolates by PCR.

Authors:  Wanda B Songy; Kathryn L Ruoff; Richard R Facklam; Mary J Ferraro; Stanley Falkow
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 9.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Association of Streptococcus bovis bacteremia with bowel disease.

Authors:  J G Reynolds; E Silva; W M McCormack
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.